d-mna
Generic: doxorubicin hydrochloride·Code: SKNJCT-001, SKNJCT-002, SKNJCT-003, SKNJCT-004
d-mna: developed by 1 company. Updated within the last hour.
Lead developer: Medicus Pharma Ltd. (MDCX)
Development Pipeline (1)
| Company | Phase |
|---|---|
| Medicus Pharma Ltd. (MDCX) | Phase 2 |
Analyze Medicus Pharma Ltd. & d-mna with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company